MEDIUM confidence: 100% data completeness, but the composite (51) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $9.4B— | $17.2B+82.4% | $9.7B-43.8% | $8.7B-9.9% | $10.8B+23.6% |
| EPS (dil.) | $3.00— | $3.27+9.0% | $6.95+112.5% | $4.25-38.8% | $6.17+45.2% |
| Free Cash Flow | $1.6B— | $3.7B+125.1% | $2.9B-21.9% | $2.8B-2.6% | $2.6B-8.7% |
| Gross Margin | 37.0% | 26.0%-11.0pp | 64.7%+38.7pp | 51.1%-13.5pp | 34.3%-16.8pp |
| Operating Margin | 27.1% | 19.6%-7.5pp | 52.1%+32.5pp | 37.7%-14.4pp | 33.3%-4.4pp |
| Net Margin | 17.3% | 14.5%-2.8pp | 44.0%+29.5pp | 28.8%-15.2pp | 27.8%-1.1pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Buy-rated share 0% → 0% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $1.01 | $2.14 | +111.9% |
| May 2026 | $1.15 | $0.38 | -67.0% |
| Feb 2026 | $1.11 | $2.38 | +114.4% |
| Oct 2025 | $1.02 | $0.81 | -20.6% |
| Aug 2025 | $0.96 | $0.91 | -5.2% |
| May 2025 | $1.06 | $1.08 | +1.9% |
| Feb 2025 | $1.07 | $1.05 | -1.9% |
| Oct 2024 | $0.97 | $1.08 | +11.3% |
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 20.3%/yr (revenue basis).
Base free cash flow $2.8B (avg FY2023–FY2025; latest year $2.6B) · equity value $33.0B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
No recent open-market insider transactions.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
The QScore of 51 indicates a neutral outlook for CQP, driven by a mix of factors. The stock scores high on profitability, with an impressive ROE near 104%, and exhibits strong momentum, having returned 27% over the past year. However, its value score is dragged down by a relatively high P/B of 8.9, and growth is tempered by a decline in free cash flow, while risk factors such as low beta and high volatility also impact the overall score.